Turn-around-time (TAT) ranges are listed in calendar days.
| Test |
TAT |
 |
| ABCA3-Related Surfactant Dysfunction |
7-14 |
 |
| ABCC8 Gene Sequence Analysis |
14-28 |
|
| Alagille AMPLIFIED™ |
21-28 |
|
| Alpha-1-Antitrypsin Deficiency |
10-21 |
|
| Angelman Syndrome SEQUENCE™ |
7-35 |
|
| Angelman Syndrome Methylation Analysis |
7-14 |
|
| Angelman-like, X-linked Syndrome |
14-28 |
|
| Ashkenazi Jewish FlexPanel |
10-21 |
|
| Beta Thalassemia Plus |
10-21 |
|
| Canavan AMPLIFIED™ |
14-28 |
|
| CDKL5-Related Infantile Spasms & Atypical Rett Syndrome |
14-28 |
|
| CHARGE Syndrome |
14-28 |
|
| Chromosomal Microarray: Ambry CMA: 105k Oligo Array |
7-14 |
|
| Chymotrypsin C Gene Sequence Analysis |
14-21 |
|
| Cong. Central Hypoventilation Syndrome |
10-21 |
|
| Congenital Hyperinsulinism: Ambry SEQUENCE™ |
14-49 |
|
| Cystic Fibrosis 508 FIRST™ |
3-5 |
|
| Cystic Fibrosis CF AMPLIFIED™ |
15-35 |
|
| Cystic Fibrosis Gene Sequence Analysis |
14-28 |
|
| Cystic Fibrosis CF Del/Dup |
7-14 |
|
| Cystic Fibrosis TG Repeat |
10-14 |
|
| Diamond-Blackfan Anemia: Ambry SEQUENCE™ |
21 - 42 |
|
| DKC1 Gene Sequence Analysis |
14 - 21 |
|
| Dyskeratosis Congenita: Ambry SEQUENCE™ |
14 - 49 |
|
| Fabry Disease |
10-14 |
|
| Familial Hypercholesterolemia AMPLIFIED™ |
14-28 |
|
| Familial Hypocalciuric Hypercalcemia (FHH) |
14-21 |
|
| Gaucher Disease |
14-21 |
|
| GCK Gene Sequence Analysis |
10-21 |
|
GLUD1 Gene Sequence Analysis
(Congenital Hyperinsulinism and Hyperinsulinism-Hyperammonemia Syndrome) |
14-21 |
|
| Glutaric Acidemia Type 1 |
14-21 |
|
| Glycogen Storage Disease Type Ia |
14-21 |
|
| Glycogen Storage Disease Type Ib |
14-21 |
|
| Hearing Loss, Aminoglycoside-Related MT-RNR1 |
10-21 |
|
| Hereditary Angioedema |
21-28 |
|
| HHT AMPLIFIED™ |
14-28 |
|
| HHT Del/Dup |
7-14 |
|
| HHT SMAD4 |
10-21 |
|
| HNF4A Gene Sequence Analysis |
10-21 |
|
| HNPCC SEQUENCE™ |
14-56 |
|
| HNPCC AMPLIFIED™ |
14-35 |
|
| HNPCC, MLH1-Related |
14-21 |
|
| HNPCC, MSH2-Related |
14-21 |
|
| HNPCC, MSH6-Related |
14-21 |
|
| Hunter Syndrome |
14-21 |
|
| Hurler Syndrome |
14-21 |
|
| INS Gene Sequence Analysis |
10-14 |
|
| IPF1 Gene Sequence Analysis (Diabetes) |
10-21 |
|
| IPF Telomerase (Pulmonary Fibrosis) |
10-21 |
|
| Juvenile Polyposis AMPLIFIED™ |
14-28 |
|
| KCNJ11 Gene Sequence Analysis |
10-21 |
|
| KRAS Gene sequence analysis |
14-21 |
|
| LEOPARD Syndrome |
14-21 |
|
| Maternal Cell Contamination |
10-14 |
|
| MECP2 AMPLIFIED™ |
21-35 |
|
| MECP2 Del/Dup |
7-14 |
|
| MECP2 Gene Sequence Analysis |
14-21 |
|
| Methylation Analysis |
7-14 |
|
| MODY: Ambry SEQUENCE™ |
10-49 |
|
| Multiple Endocrine Neoplasia Type1 |
14-21 |
|
| Multiple Endocrine Neoplasia Type 2 SEQUENCE™ |
14-21 |
|
| Niemann-Pick Disease Types A & B |
14-21 |
|
| Neonatal Diabetes: Ambry SEQUENCE™ |
10-49 |
|
| Noonan Syndrome: Ambry SEQUENCE™ |
14-42 |
|
| Noonan/LEOPARD Syndrome: Ambry SEQUENCE™ |
14-42 |
|
| PAH AMPLIFIED™ |
14-28 |
|
| PAH Del/Dup |
7-14 |
|
| PALB2-Related Cancer |
14-28 |
|
| Pancreatitis Panel |
21-35 |
|
| Pancreatitis Panel AMPLIFIED™ |
28-42 |
|
| PCD 61™ |
10-21 |
|
| Peutz-Jeghers AMPLIFIED™ |
21-28 |
|
| PKU (Phenylketonuria) |
14-21 |
|
| Pompe Disease |
14-28 |
|
| Prader-Willi Methylation Analysis |
7-14 |
|
| PRSS1 Gene Sequence Analysis |
14-28 |
|
| PTEN-Related Disorders |
14-21 |
|
| PTP11 Gene sequence analysis |
14-21 |
|
| RAF1 Gene sequence analysis |
14-21 |
|
| RCAD/MODY5 AMPLIFIED™ |
10-21 |
|
| RET-Related Hirschsprung Disease SEQUENCE™ |
14-21 |
|
| Rett Syndrome: Ambry SEQUENCE™ |
14-49 |
|
| RPS19 Gene Sequence Analysis |
10-21 |
|
| RPL5 or RPL11 Gene Sequence Analysis |
14-28 |
|
| RPS7, RPS17, or RPS24 Gene Sequence Analysis |
14-28 |
|
| Shwachman - Diamond Syndrome |
10-21 |
|
| Smith-Lemli-Opitz Syndrome, SLOS |
14-21 |
|
| Specific Mutation Analysis (any gene, 1 or more mutations) |
10-14 |
|
| SPINK1 Gene Sequence Analysis |
14-28 |
|
| SOS1 Gene sequence analysis |
14-21 |
|
| Surfactant Protein B |
5-10 |
|
| Surfactant Protein C |
5-10 |
|
| Tay-Sachs Plus |
14-28 |
|
| TCF1 Gene Sequence Analysis |
10-21 |
|
| TCF2 RCAD/MODY5 AMPLIFIED™ |
10-21 |
|
| TINF2-Partial Gene Sequence Analysis |
7 - 10 |
|
| Transthyretin Amyloidosis |
10-21 |
|
| UBEA3-Related Angelman Syndrome |
14-21 |
|
| Von Hippel-Lindau Disease |
10-21 |
|
| Warfarin Sensitivity |
7-10 |
|
| Wilson Disease |
14-28 |
| |
100 Columbia #200, Aliso Viejo, CA 92656